Wellington Management Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Wellington Management Group’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-764,300	Closed	-$2.37M	–	2358
2021 Q4	$2.37M	Buy	+764,300	New	+$2.57M	﹤0.01%	1625
2016 Q2	–	Sell	-14,236	Closed	-$46K	–	2277
2016 Q1	$46K	Sell	14,236 -1,761,972	-99%	-$6.51M	﹤0.01%	2099
2015 Q4	$8.51M	Buy	1,776,208 +60,308	+4%	+$342K	﹤0.01%	1217
2015 Q3	$9.54M	Buy	+1,715,900	New	+$12.7M	﹤0.01%	1185
2014 Q3	–	Sell	-380,397	Closed	-$4.59M	–	2328
2014 Q2	$4.59M	Buy	380,397 +185,866	+96%	+$1.76M	﹤0.01%	1480
2014 Q1	$1.64M	Buy	+194,531	New	+$1.57M	﹤0.01%	1732
2013 Q4	–	Sell	-25,500	Closed	-$138K	–	2337
2013 Q3	$138K	Sell	25,500 -182,100	-88%	-$875K	﹤0.01%	2149
2013 Q2	$843K	Buy	+207,600	New	+$974K	﹤0.01%	1804

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Wellington Management Group's BDSI Position: Q1 2022 in Review

Wellington Management Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 764,300 shares — an estimated $2.37M sold.

Wellington Management Group first reported a position in BDSI in Q2 2013 and held it in 8 quarters. The position peaked at $9.54M in Q3 2015. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Wellington Management Group reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Wellington Management Group sold 764,300 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $2.37M.
Wellington Management Group first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 8 quarters.
Wellington Management Group's BioDelivery Sciences International, Inc. position peaked at $9.54M in Q3 2015.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Wellington Management Group's 13F filing for Q1 2022, filed 16 May 2022.